Active Protocols

Summary of US Cooperative Group Clinical Brachytherapy Trials

(As of October 24, 2017)


NRG GY006A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer



RTOG 0724Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-risk Patients with early-stage Cervical Carcinoma Following Radical Hysterectomy

RTOG 0924Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

RTOG 1203 (Temporary Closure)A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation For Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)



GOG 0238A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients with Pelvic-only Recurrence of Carcinoma of the Uterine Corpus

GOG 0263Randomized Phase III Clinical Trial Of Adjuvant Radiation Versus Chemoradiation In Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy And Pelvic Lymphadenectomy

GOG 0279A Phase II Trial Evaluating Cisplatin (NSC #119875) and Gemcitabine (NSC #613327) Concurrent With Intensity-Modulated Radiation Therapy (IMRT) In The Treatment Of Locally Advanced Squamous Cell Carcinoma Of The Vulva